BioMarin Announces Second Quarter 2020 Total Revenue Growth of 11% to $430 million
Go back to BioMarin Announces Second Quarter 2020 Total Revenue Growth of 11% to $430 million| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 64.41 -0.22 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.63 | 52 Week High | $108.96 | |||
| Open | $63.83 | 52 Week Low | $62.12 | |||
| Day High | $65.33 | P/E | N/A | |||
| Day Low | $63.64 | EPS | $-1.27 | |||
| Volume | 1,949,630 | |||||
